Preclinical Evidence of the Efficacy of Lewis Y Car T Cells in Patient-Derived Models of Prostate Cancer

Chimeric antigen receptor T (CAR T) cell therapy is an adoptive immunotherapy that has led to new treatments for lymphoma, leukemia, and other blood cancers; however, its efficacy for prostate cancer remains unproven. Here we report pre-clinical evidence of the efficacy of CAR T cell therapy against...

Descripción completa

Detalles Bibliográficos
Autores principales: Risbridger, Gail Petuna, Porter, Laura Helen, Zhu, Joe, Byrne, David, Lister, Natalie, Azad, Arun, Hofman, Michael, Vela, Ian, Taylor, Renea A, Neeson, Paul, Darcy, Phil, Trapani, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089198/
http://dx.doi.org/10.1210/jendso/bvab048.2106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089198/
http://dx.doi.org/10.1210/jendso/bvab048.2106

Ejemplares similares